The U.S. Securities and Exchange Commission charged a former executive of Medivation Inc. with insider trading Tuesday in California Northern District Court. The suit accuses Matthew Panuwat, Medivation's former head of business development, of conducting trades in 2016 based on advance knowledge of Medivation's acquisition by Pfizer. Attorneys have not yet appeared for the defendant. The case is 3:21-cv-06322, Securities and Exchange Commission v. Panuwat.